The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX.

Eur Heart J · 2016 · PMC4823635 · PMID 26400827

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the interaction tests for access site did not reach statistical significance, when the primary composite endpoint was evaluated according to access site, cangrelor demonstrated a reduction in odds of ischaemic events among patients undergoing femoral PCI.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.